Price and reimbursement for orphan medicines and managed entry agreements: does Italy need a framework?

This article illustrates a consensus opinion of an expert panel on the need and usefulness of a framework for price and reimbursement (P&R) process and managed entry agreements (MEAs) for orphan medicines in Italy. This opinion was gathered in three rounds: an introductory document was sent to t...

Descripción completa

Detalles Bibliográficos
Autores principales: Jommi, Claudio, Addis, Antonio, Martini, Nello, Nicod, Elena, Pani, Marcello, Scopinaro, Annalisa, Vogler, Sabine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AboutScience 2021
Materias:
Point of View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616180/
https://www.ncbi.nlm.nih.gov/pubmed/36627869
http://dx.doi.org/10.33393/grhta.2021.2278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616180/
https://www.ncbi.nlm.nih.gov/pubmed/36627869
http://dx.doi.org/10.33393/grhta.2021.2278

Ejemplares similares